Controls | PD | P-value | |
---|---|---|---|
Number | 11 | 17 | |
Age (year) | 63 (59–64) | 66 (60–72) | 0.138 |
Female (%) | 55 | 47 | 0.700 |
Systolic BP (mmHg) | 125 ± 14 | 129 ± 20 | 0.580 |
Diastolic BP (mmHg) | 75 ± 8 | 76 ± 11 | 0.768 |
Heart rate (beats/min) | 64 ± 11 | 64 ± 9 | 0.956 |
Duration of disease (months) | - | 33.5 ± 7.2 | |
UPDRS Part 2 (points) | - | 10.0 ± 1.4 | |
UPDRS Part 3 (points) | - | 17.7 ± 2.3 | |
H&Y stage | - | 2.0 (1.5–3.0) | |
LEDD (mg/day) | - | 386 ± 279 | |
Constipation (%) | 9 | 76 | < 0.001 |
CVRR, rest (%) | 3.7 (1.8–5.9) | 2.6 (1.7–4.0) | 0.359 |
CVRR, deep breath (%) | 4.4 (3.9–6.8) | 2.8 (2.1–4.0) | 0.018 |
Early H/M ratio | - | 1.92 ± 0.56 | |
Delayed H/M ratio | - | 1.69 ± 0.71 | |
Orthostatic hypotension (%) | 0 | 35 | 0.026 |
LF power, supine (ms2) | 169 (126–427) | 70 (47–307) | 0.086 |
HF power, supine (ms2) | 279 (85–342) | 65 (27–302) | 0.070 |
LF/HF ratio, supine | 1.22 (0.78–3.33) | 1.47 (0.72–2.76) | 0.814 |
LF power, standing (ms2) | 125 (65–542) | 84 (41–198) | 0.115 |
HF power, standing (ms2) | 62 (43–82) * | 40 (15–127) | 0.589 |
LF/HF ratio, standing | 3.74 (1.87–9.4) | 2.52 (0.86–7.74) | 0.438 |